Media headlines about Sabra Healthcare REIT (NASDAQ:SBRA) have been trending somewhat positive on Saturday, Accern reports. Accern ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Sabra Healthcare REIT earned a news impact score of 0.25 on Accern’s scale. Accern also assigned news stories about the real estate investment trust an impact score of 45.651589901791 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Here are some of the news stories that may have impacted Accern Sentiment’s rankings:
- Sabra Healthcare REIT, Inc. (SBRA) Receives Consensus Rating of “Hold” from Analysts (americanbankingnews.com)
- Sabra Health Care REIT Inc (NASDAQ:SBRA) Sentiment Improved in Q4 2016 (topactu.net)
- Maintains Stake in Sabra Healthcare REIT, Inc. (SBRA) (famososartistas.com)
- Sabra and Care Capital Properties Complete Merger (finance.yahoo.com)
- Sabra Healthcare REIT, Inc. Expected to Post Q3 2017 Earnings of $0.61 Per Share (SBRA) (americanbankingnews.com)
Several brokerages have commented on SBRA. Mizuho downgraded shares of Sabra Healthcare REIT from a “neutral” rating to an “underperform” rating and cut their price target for the company from $25.00 to $23.00 in a report on Monday, July 10th. BidaskClub raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Wednesday, July 19th. Canaccord Genuity reissued a “hold” rating and issued a $26.00 price target on shares of Sabra Healthcare REIT in a report on Tuesday, May 9th. Stifel Nicolaus reissued a “hold” rating and issued a $26.00 price target on shares of Sabra Healthcare REIT in a report on Friday, July 28th. Finally, Jefferies Group LLC raised shares of Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $25.00 price target for the company in a report on Tuesday. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $27.00.
Shares of Sabra Healthcare REIT (NASDAQ SBRA) opened at 20.71 on Friday. Sabra Healthcare REIT has a 52-week low of $19.30 and a 52-week high of $29.10.
The business also recently announced a dividend, which was paid on Friday, August 18th. Investors of record on Wednesday, August 16th were given a dividend of $0.3599 per share. The ex-dividend date was Monday, August 14th. Sabra Healthcare REIT’s dividend payout ratio is 145.76%.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.